Ovarian Cancer

This information is useful for adults and older adults
iStock-642066430.jpg
Why Yale Medicine?
  • We are determined to catch ovarian cancer early and treat it with the latest therapies.
  • Our Discovery to Cure has helped determine which screening tests best spot early cancer.
  • Participants in our clinical trials can receive access to promising new drugs or treatments.

The most effective tool physicians have in treating ovarian cancer is early detection. But this is not always easy, explains Yale Medicine's Elena Ratner, MD, because ovarian cancer is known as "the cancer that whispers."

"When women get diagnosed, what they usually want to know is how long have they had this cancer," says Dr. Ratner, co-chief of Gynecologic Oncology and an assistant professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine. "Frequently, women will not have any symptoms until they get diagnosed and their cancer is at more advanced stages."

Catching ovarian cancer early greatly improves the odds a woman will make a full recovery.  At Yale Medicine, our approach to ovarian and other gynecological cancers is rooted in a program called Discovery to Cure, which combines cutting-edge laboratory research with a team approach to patient care using the latest early-detection methods.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.